ethylestrenol has been researched along with Arteriosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, E; Hata, Y; Tsushima, M | 1 |
| Naimi, S; Proger, S | 1 |
| Chakrabarti, R; Evans, JF; Fearnley, GR | 1 |
2 trial(s) available for ethylestrenol and Arteriosclerosis
| Article | Year |
|---|---|
Primary prevention of atherosclerotic vascular disease with ethylnandrol. An interim report of four-year observations.
Topics: Adult; Aged; Arteriosclerosis; Aspartate Aminotransferases; Blood Pressure; Cholesterol; Clinical Trials as Topic; Ethylestrenol; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Japan; Male; Middle Aged; Myocardial Infarction; Placebos; Serum Globulins; Solubility; Triglycerides | 1975 |
Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
Topics: Adult; Aged; Arteriosclerosis; Arthritis, Rheumatoid; Blood Coagulation; Clinical Trials as Topic; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Phenformin; Placebos; Time Factors; Vascular Diseases | 1969 |
1 other study(ies) available for ethylestrenol and Arteriosclerosis
| Article | Year |
|---|---|
Fibrinolytic activity and coronary-artery disease.
Topics: Arteriosclerosis; Ethylestrenol; Fibrinolytic Agents; Humans; Myocardial Infarction; Phenformin | 1968 |